Robert W. Baird Cuts Owens & Minor (NYSE:OMI) Price Target to $14.00

Owens & Minor (NYSE:OMI) had its price objective decreased by equities research analysts at Robert W. Baird from $19.00 to $14.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Robert W. Baird’s price objective suggests a potential upside of 16.67% from the company’s current price.

Other equities research analysts also recently issued research reports about the company. Barclays cut their price target on Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating on the stock in a report on Monday, August 5th. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. Citigroup upgraded shares of Owens & Minor from a “neutral” rating to a “buy” rating and lowered their price target for the stock from $24.00 to $19.00 in a report on Friday, July 19th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research report on Wednesday, August 21st. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $19.29.

Owens & Minor Stock Performance

Shares of Owens & Minor stock opened at $12.00 on Tuesday. The company has a debt-to-equity ratio of 2.17, a current ratio of 1.09 and a quick ratio of 0.51. The stock has a market capitalization of $925.20 million, a price-to-earnings ratio of -21.43, a price-to-earnings-growth ratio of 0.43 and a beta of 0.41. The business has a 50-day moving average of $14.62 and a 200 day moving average of $16.28. Owens & Minor has a 12 month low of $11.75 and a 12 month high of $28.35.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.02. The firm had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.68 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. The business’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.44 earnings per share. As a group, sell-side analysts forecast that Owens & Minor will post 1.57 earnings per share for the current year.

Institutional Trading of Owens & Minor

Institutional investors and hedge funds have recently bought and sold shares of the business. Wolverine Asset Management LLC increased its stake in Owens & Minor by 21.1% in the third quarter. Wolverine Asset Management LLC now owns 166,430 shares of the company’s stock valued at $2,611,000 after purchasing an additional 29,000 shares during the period. Allspring Global Investments Holdings LLC increased its position in Owens & Minor by 383.9% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 29,376 shares of the company’s stock valued at $461,000 after acquiring an additional 23,305 shares during the period. Blue Trust Inc. raised its stake in Owens & Minor by 176.8% during the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after acquiring an additional 1,780 shares during the last quarter. Inspire Advisors LLC acquired a new stake in Owens & Minor during the 3rd quarter worth approximately $217,000. Finally, SG Americas Securities LLC purchased a new position in shares of Owens & Minor in the 3rd quarter valued at approximately $494,000. Hedge funds and other institutional investors own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.